These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8172200

  • 1. Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation.
    Dimopoulos MA, Yau JC, Huan SD, Jagannath S, Spitzer G, Spinolo JA, Zagars GK, LeMaistre CF, Dicke KA, Zander AR.
    Am J Hematol; 1994 Jun; 46(2):82-6. PubMed ID: 8172200
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Jun; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 3. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL.
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [Abstract] [Full Text] [Related]

  • 4. High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications.
    Bradley J, Reft C, Goldman S, Rubin C, Nachman J, Larson R, Hallahan DE.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):391-6. PubMed ID: 9457826
    [Abstract] [Full Text] [Related]

  • 5. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D, Labar B, Bogdanic V, Skodlar J, Petrovecki M, Mrsic M, Maravic N, Sneller V, Radman I, Kovacevic-Metelko J.
    Wien Med Wochenschr; 1995 Jan 15; 145(2-3):61-4. PubMed ID: 7762256
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B, Weisdorf DJ, Kim T, Kersey JH, Ramsay NK.
    Bone Marrow Transplant; 1990 Feb 15; 5(2):83-9. PubMed ID: 2107007
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
    Ozsahin M, Belkacémi Y, Pène F, Laporte J, Rio B, Leblond V, Korbas D, Touboul E, Gorin NC, Schlienger M, Laugier A.
    Int J Radiat Oncol Biol Phys; 1996 Jan 01; 34(1):71-7. PubMed ID: 12118567
    [Abstract] [Full Text] [Related]

  • 9. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings.
    Zecca M, Pession A, Messina C, Bonetti F, Favre C, Prete A, Cesaro S, Porta F, Mazzarino I, Giorgiani G, Rondelli R, Locatelli F.
    J Clin Oncol; 1999 Jun 01; 17(6):1838-46. PubMed ID: 10561223
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
    Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I, Klein JL, Kapoor N, Harman GS, Avalos BR.
    Semin Oncol; 1993 Aug 01; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
    [Abstract] [Full Text] [Related]

  • 11. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O, Labopin M, Tura S, Arcese W, Iriondo A, Zittoun R, Sierra J, Gorin NC.
    Br J Haematol; 1996 Jun 01; 93(3):637-45. PubMed ID: 8652385
    [Abstract] [Full Text] [Related]

  • 12. Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse.
    Scarpati D, Frassoni F, Vitale V, Corvo R, Franzone P, Barra S, Guenzi M, Orsatti M.
    Int J Radiat Oncol Biol Phys; 1989 Sep 01; 17(3):547-52. PubMed ID: 2674077
    [Abstract] [Full Text] [Related]

  • 13. Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
    Demirer T, Buckner CD, Appelbaum FR, Lambert K, Bensinger WI, Clift R, Storb R, Slattery JT.
    Bone Marrow Transplant; 1996 Mar 01; 17(3):341-6. PubMed ID: 8704684
    [Abstract] [Full Text] [Related]

  • 14. Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia.
    Horwitz LJ, Kantarjian HM, Jagannath S, Keating MJ, McCredie KB, Spitzer G, Vellekoop L, Zander AR, Dicke KA.
    Bone Marrow Transplant; 1989 Jan 01; 4(1):101-5. PubMed ID: 2647172
    [Abstract] [Full Text] [Related]

  • 15. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
    Fyles GM, Messner HA, Lockwood G, Curtis JE, Rider W, Minden MD, Meharchand JM, Lipton J, Tritchler D, Van Dyk J.
    Bone Marrow Transplant; 1991 Dec 01; 8(6):453-63. PubMed ID: 1790425
    [Abstract] [Full Text] [Related]

  • 16. Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
    Petersen FB, Buckner CD, Appelbaum FR, Clift RA, Sanders JE, Bensinger WI, Storb R, Witherspoon RP, Sullivan KM, Bearman SI.
    Bone Marrow Transplant; 1989 Nov 01; 4(6):617-23. PubMed ID: 2684307
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.
    Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Bush SA, Hui TE, Martin PJ, Mitchell D, Press OW.
    Blood; 1995 Feb 15; 85(4):1122-31. PubMed ID: 7849300
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T, Kojima S, Kato K.
    Bone Marrow Transplant; 1998 Jul 15; 22(1):21-6. PubMed ID: 9678791
    [Abstract] [Full Text] [Related]

  • 20. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May 15; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.